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Objective: Osteoarthritis (OA) is currently diagnosed using clinical and radiographic ﬁndings. In recent
years magnetic resonance imaging (MRI) use in OA has increasingly been studied. This study was
conducted to determine the diagnostic utility of MRI in OA through a meta-analysis of published studies.
Methods: A systematic literature search was undertaken to include studies that used MRI to evaluate or
detect OA. MRI was compared to various reference standards: histology, arthroscopy, radiography, CT,
clinical evaluation, and direct visual inspection. Sensitivity, speciﬁcity, positive predictive value (PPV),
negative predictive value (NPV), and receiver operating characteristic (ROC) area under the curve (AUC)
were calculated. Random-effects models were used to pool results.
Results: Of 20 relevant studies identiﬁed from the literature, 16 reported complete data and were
included in the meta-analysis, with a total of 1220 patients (1071 with OA and 149 without). Overall
sensitivity from pooling data of all the included studies was 61% [95% conﬁdence interval (CI) 53e68],
speciﬁcity was 82% (95% CI 77e87), PPV was 85% (95% CI 80e88), and NPV was 57% (95% CI 43e70). The
ROC showed an AUC of 0.804. There was signiﬁcant heterogeneity in the above parameters (I2> 83%).
With histology as the reference standard, sensitivity increased to 74% and speciﬁcity decreased to 76%
compared with all reference standards combined. When arthroscopy was used as the reference standard,
sensitivity increased to 69% and speciﬁcity to 93% compared with all reference standards combined.
Conclusion: MRI can detect OA with an overall high speciﬁcity and moderate sensitivity when compared
with various reference standards, thus lending more utility to ruling out OA than ruling it in. The
sensitivity of MRI is below the current clinical diagnostic standards. At this time standard clinical
algorithm for OA diagnosis, aided by radiographs appears to be the most effective method for diagnosing
OA.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a disease of the synovial joint tissues in
which there is destruction of synovial joint tissues and active, but
ineffective attempts at repair.1 This structural change can lead to
pain and disability. In fact, the risk for disability caused by OA is on
par with that of cardiovascular disease and greater than that due to
any other medical condition in the elderly.2 Despite this, the: D.J. Hunter, Rheumatology
Clinical School, University of
; Fax: 61-2-9906-1859.
Hunter).
s Research Society International. Paetiology and pathology of OA are not well understood. This
contributes to the discrepancy between pathological evidence for
the disease and clinical symptoms.3 Because of this inconsistency,
no single measure is used for diagnosis in OA, but rather a combi-
nation of tools, which yields better diagnostic performance than
does any one of those tools on its own.
Currently, the diagnosis of knee OA in the clinic is most often
made using the 1986 criteria of the American College of Rheuma-
tology. These criteria include a combination of the patient’s age,
signs and symptoms on physical exam, radiographic and/or labo-
ratory evidence.4 When the radiograph is used along with physical
exam, the sensitivity and speciﬁcity of this method are 91% and
86%, respectively. Using a classiﬁcation and regression tree
technique (CART) with clinical, radiographic and laboratoryublished by Elsevier Ltd. All rights reserved.
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mid-ninety percent range.4 These diagnostic techniques are
relatively inexpensive and readily available. More recently, The
European League Against Rheumatism (EULAR) OA Task Force
suggested that a conﬁdent clinical diagnosis of knee OA may be
made according to three symptoms (persistent knee pain, morning
stiffness and reduced function) and three signs (crepitus, restricted
movement and bony enlargement).5 Although the American
College of Rheumatology (ACR) or EULAR criteria remain the
standard for diagnosis both in the clinic and in research, magnetic
resonance imaging (MRI) has been increasingly used as well.6
Before widespread use of MRI in clinical practice is adopted
reasoned debate of the strengths and weaknesses of this method
should be considered. Cost concerns, lack of clarity about diagnostic
performance and little standardization regarding MRI interpreta-
tion has made it unclear whether this increased use of MRI in
clinical practice is rational. In contrast to X-ray, MRI can visualize all
tissues in the joint involved in OA: cartilage, menisci, bone, and soft
tissue. In addition, MRI causes no ionizing radiation exposure.
While it does not have the distortions and magniﬁcation problems
inherent in radiographs, MRI does have its own motion and
susceptibility artifacts. MRI also requires several different pulse
sequences to visualize speciﬁc tissue types, and its use requires
determining the best sequences for various features. Since 1988,
numerous studies have examined the use of MRI in imaging
synovial inﬂammation, meniscus pathology, cartilage morphology
alteration, bone marrow lesions, osteophytes, cartilage composi-
tion, and other markers along with their correlation with clinically
deﬁned OA.7 The predictive value and diagnostic performance of
some of these markers have also been studied.8,9
One hope in testing the diagnostic utility of MRI in OA is to ﬁnd
and use some of those features undetectable by other
imaging modalities, thus potentiating an earlier diagnosis of OA or
a diagnosis of pre-osteoarthritis (pre-OA), in those patients lacking
clinical symptoms. This would allow for therapeutic trials aimed at
altering the preliminary course of OA and attempting to prevent
many of the later degenerative changes which have already occurred
once the disease is detected by clinical exam and radiographic
change. Such an early diagnosis has not been possible with the
current standard techniques discussed above. However a recent
study has proposed a deﬁnition of OA based onMRI using the Delphi
method in an attempt to move towards detecting earlier disease.10Fig. 1. Flow chart of the screening process forDespite the growing pool of information, there is little unifor-
mity in the diagnostic application of MRI and a lack of its conﬁrmed
diagnostic utility, as noted in the “Evidence Based Recommenda-
tions for the Diagnosis of Knee OA” published by EULAR in 2009.5
Over the last decade we have gained a better understanding of
the many individual features on MRI, their clinical and pathologic
signiﬁcance, and how to use many of them quantitatively.11 As yet
however the diagnostic performance of MRI for OA has not been
adequately studied. The objective of this meta-analysis was to
evaluate, and determine the factors affecting, the diagnostic
performance of MRI in the setting of OA.
Methods
Systematic literature search
An online literature search was conducted of the OVIDMEDLINE
(1945-), Embase (1980-), and Cochrane databases (1998-) of articles
published up to the time of the search, April 2009, with the search
entries “MRI”, and “osteoarthritis”, “osteoarthritides”, “osteo-
arthrosis”, “osteoarthroses”, “degenerative arthritis”, “degenerative
arthritides”, or “osteoarthritis deformans”. The abstracts of the
1330 citations received with this search were then preliminarily
screened for relevance by two reviewers (KH and DJH). For this
preliminary search, all articles which used MRI, in some form, on
patients with OA of the knee, hip, or hand were included. Although
review articles were not included (see Inclusion/exclusion criteria),
citations found in any review articles which were not already
included in our preliminary search were screened for possible
inclusion in this study. This added seven more relevant studies to
our search. One further article was added by one of the authors of
this meta-analysis bringing the preliminary total to 1338.
Inclusion/exclusion criteria
Only studies published in English were included. Studies
presenting non-original data were excluded, such as reviews,
editorials, opinion papers, or letters to the editor. Studies using
non-human subjects or specimens were excluded. Studies in which
rheumatoid, inﬂammatory, or other forms of arthritis were
incorporated in the OA datasets were excluded, as well as general
joint-pertinent MRI studies not focused on OA. Studies with noarticles included in the systematic review.
Table I
Study attributes and population characteristics
Reference and
Pubmed ID
Total
sample
# of cases # of
controls
Age (years),
mean SD,
[range]
# (%) of females Measurement
technique used
Reference standard
used
Tissue type(s) imaged Study design Downs
score
Joint
[18]; 1609084 10 10 0 73.8, [56e88] 3 (30) Semiquantitative Histology Meniscus Cross-sectional 6 Knee
[19]; 8475293 10 10 0 [70e89] N/A Semiquantitative
and descriptive
Open visualization Cartilage Other 5 Knee
[20]; 8659356 47 32 15 36, [7e67] 14 (30) Semiquantitative Arthroscopy Cartilage Cross-sectional 6 Knee
[21]; 9119848 23 5 18 40 2 14 (61) Semiquantitative Open visualization Acetabular labrum Cross-sectional 5 Hip
[24]; 9448754 20 20 0 72.2, [62e82] 18 (90) Semiquantitative Histology Cartilage Other 8 Knee
[23]; 9529440 72 72 0 58, [41e74] 46 (64) Semiquantitative Arthroscopy Cartilage Other 6 Knee
[25]; 9616238 24 24 0 [45e68] N/A Semiquantitative Histology Cartilage Other 6 Knee
[22]; 9759121 57 57 0 N/A N/A Semiquantitative X-ray Cartilage, meniscus,
bone, subchondral
lesions
Longitudinal
Prospective
5 Knee
[26]; 9933399 320 240 80 29.3 8.7, [13e56] 122 (38.1) Semiquantitative Arthroscopy Cartilage, meniscus Cross-sectional 7 Knee
[27]; 10813184 15 15 0 N/A 9 (60) Semiquantitative Histology Acetabular labrum Other 7 Hip
[28]; 15503323 16 16 0 55.6, [40e73] 6 (38) Quantitative and
semiquantitative
Arthroscopy Cartilage, synovium,
BML, meniscus
Other 5 Knee
[29]; 16037508 18 10 8 [12e49] 17 (94) Semiquantitative Computed
Tomography (CT)
Cartilage Cross-sectional 6 Hip
[8]; 16868968 264 264 0 66.7 9.2, [47e93] 108 (40.9) Semiquantitative
and quantitative
meniscal position
X-ray Cartilage, meniscus Cross-sectional 9 Knee
[30]; 16890461 62 62 0 64.9 10.3 46 (74) Semiquantitative X-ray Cartilage, synovium,
bone, BML,
meniscus, ligament
Longitudinal
Prospective
10 Knee
[32]; 18274849 161 161 0 58.5, [11e85] 98 (60.9) Semiquantitative X-ray Effusion, meniscus,
ligament, bone bruises
Cross-sectional 8 Knee
[33]; 18491096 7 7 0 65.6 4 (57) Semiquantitative Histology Cartilage Other 5 Knee
[31]; 18562375 20 20 0 47, [26e69] 9 (45) Semiquantitative Arthroscopy Cartilage Cross-sectional 6 Hand
[35]; 19161210 31 17 14 Cases: 61.8, [40e86];
controls: 29.2, [18e40]
21 (68) Compositional
technique (dGEMRIC)
Clinical Cartilage Case control 7 Knee
[34]; 19164121 200 200 0 1.5 T image group: 38.9,
[16e63]; 3 T image
group: 39.1, [15e65]
87 (43.5) Semiquantitative Arthroscopy Cartilage Longitudinal
retrospective
10 Knee
[9]; LL-MK2083-R02 182 154 28 Case group: 56 (range:
45e65); control group:
59 (range: 44e75)
Case group:
120 (80);
control group:
21 (75)
Semiquantitative Clinical Cartilage, bone, BML,
meniscus, cysts,
effusions
Case control 11 Knee
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Table II
Measurement used and tissue type imaged by MRI in all 20 studies
No. of
studies
% of
studies
Measurement Quantitative cartilage 1 5
Compositional technique* 1 5
Semiquantitative 19 95
Descriptive 1 5
Quantitative meniscal position 1 5
Synovial joint tissue Cartilage 16 80
Synovium 2 10
Bone 3 15
Bone marrow lesions 3 15
Meniscus 8 40
Ligaments 2 10
Other 7 35
* dGEMRIC MRI enhancement for viewing of proteoglycan content of cartilage.
Table III
Reference standard used for MRI technique comparison and synovial joint tissue
assessed: number of individual datasets and studies (including all 20 studies)
Reference
standard used
Tissue
Bone Cartilage Labrum Meniscus Other Total
datasets
Total
studies
Arthroscopy 0 6 0 1 0 7 6
X-ray 3 11 0 6 0 20 4
Histology 0 5 1 1 0 7 5
Direct visualization 0 1 3 0 0 4 2
CT 0 2 0 0 0 2 1
Clinical 7 4 0 4 2 14 2
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which had somemeasure of diagnostic performancewere included.
Any duplicates which came up in the preliminary search were
excluded.
For the meta-analysis, only those articles from the systematic
review were included that had complete sensitivity and speciﬁcity
data needed to derive the true positive (TP), false positive (FP), true
negative (TN), and false negative (FN) values for that study.
Data abstraction
Of the preliminary 1338 abstracts, 243 were selected for data
abstraction of which 22 were pertinent to diagnostic performance
(Fig. 1). Two of these studies were excluded as they used MRI as the
reference standard against which X-ray techniques were
compared,12,13 leaving 20 studies. Two reviewers (KH and LM)
independently abstracted the following data: (1) patient demo-
graphics and inclusion/exclusion criteria; (2) MRI make, sequences
and techniques used, tissue types viewed; (3) study type and
funding source; (4) MRI reliability/reproducibility data; (5) which
diagnostic measures were used with MRI (e.g., cartilage thickness
measurements, lesion identiﬁcation, etc.) and their diagnostic
performance (e.g., sensitivity, speciﬁcity, etc.) when compared with
a reference standard; (6) the reference standard measures against
which the MRI measure was evaluated; (7) treatment and MRI
measures (when appropriate).
Assessment of study quality
Quality and bias assessment of the studies was performed using
the Downs Methodological Study Criteria.14
Outcome measures
The focus of this analysis was on diagnostic performance. Data
extracted on the diagnostic performance of MRI or material per-
taining to deﬁning OA on MRI was used. The ability of MRI to
discriminate betweenpatients with andwithout OA (OA in this case
is deﬁned by either clinical diagnosis, radiography, or both) was
summarized by sensitivity, speciﬁcity, positive and negative
predictive values (PPV, NPV), positive and negative likelihood ratios
(LRþ, LR) and accuracy. A LRþ above 10 or LR below 0.1 is
considered strong evidence to respectively rule in or rule out
a diagnosis inmost circumstances. The term “overall sensitivity” (or
speciﬁcity, etc.) is used to describe the results from pooling of all
the TP, FP, TN, FN data gathered from the studies included,
regardless of the reference standard and tissue type used.
Data analysis
The TP, FP, TN, FN values were derived from the sensitivity and
speciﬁcity data and from the numbers of subjects reported in each
study. From these the point estimates and their 95% conﬁdence
intervals (CIs) of the sensitivity, speciﬁcity, PPV, and NPV were
calculated. Positive and negative likelihood ratios were computed
using the standard formulas: LRþ¼ sensitivity/(1speciﬁcity) and
LR¼ speciﬁcity/(1sensitivity). The area under the receiver
operating characteristic (ROC) curve or AUC was also calculated.
ROC presents a curve of sensitivity (y-axis) against 1speciﬁcity
(x-axis) at different cut-off points (e.g., deciles) of the MRI
measures. ROC quantiﬁes the overall ability of a diagnostic test to
classify diseased and non-diseased individuals correctly. Larger
values of ROC (range between 0 and 1) indicate good discriminative
power.15 The DerSimonian and Laird method16 for random-effects
models was used to pool individual estimates. Heterogeneity wasassessed across the studies using the Cochran Q statistic and
inconsistency, I2 which represents the percent variance across all
studies attributable to heterogeneity rather than to chance;
a higher value indicates more heterogeneity.17 Random-effects
models and inconsistency were calculated for the sub-groups of
histology, arthroscopy, and X-ray as reference standards. Statistical
signiﬁcance was set at 0.05 and CIs calculated at 95%.Results
We identiﬁed 20 studies which met our inclusion criteria and
contained relevant diagnostic measure and performance
data.8,9,18e35 Study attributes and population characteristics are
presented in Table I. The studies included a total of 1559 patients,
1396 with OA and 163 without OA. A large majority of the studies
used semiquantitativeMRI measurement techniques for measuring
OA (Table II). Various tissues were imaged in the different studies.
Cartilage was examined in the majority of studies (16 studies,
Table II). The other commonly viewed tissue types were meniscus
(eight), synovium (two), bone (three), and bone marrow lesions
(three). As the reference standard measure against which the MRI
diagnostic techniques were compared, arthroscopy was used most
prevalently, followed by histological section and X-ray (Table III).
Sixteen of the original 20 papers were included in the meta-
analysis because four lacked complete sensitivity and speciﬁcity
data needed to derive the TP, FP, TN, FN data.8,24,25,35 A total of 1220
patients were included in the meta-analysis, 1071 with OA and 149
without OA. In ﬁve of the 16 studies more than one parameter was
analysed (e.g., tissue type, deﬁned endpoint) which created sepa-
rate datasets in our analyses.9,21,22,29,33 Overall sensitivity of all the
datasets from the random-effects model was 61% (95% CI 53e68)
(Fig. 2), speciﬁcity from the random-effects model was 82% (95% CI
77e87) (Fig. 3), PPV was 85% (95% CI 80e88), and NPV 57% (95% CI
43e70; Table IV). LRþ was 3.22 (95% CI 2.33e4.45) and LR was
0.48 (95% CI 0.40e0.59). Overall accuracy was 69% (95% CI 61e76).
Fig. 2. Plot showing sensitivity of MRI use in OA viewing various tissue types in the 16 studies with complete data.
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(Fig. 4).
There was signiﬁcant heterogeneity in all of the parameters
listed above (I2> 83%). Consistent with this, the funnel plots
including all the data show marked variability for individual point
estimates, more so with sensitivity than speciﬁcity (Figs. 5 and 6).
The diagnostic performance of MRI varied markedly depending
onwhich reference standard it was compared to. In general theMRI
sensitivity was better when it was compared to the tissue of
interest directly (e.g., arthroscopy, histology, open inspection) as
distinct from X-ray and clinical information, whereas speciﬁcity
was superior with arthroscopy, worst with open inspection, with
histology and X-ray in between. Using histology as the reference
standard the sensitivity increases to 74% (95% CI 65e81) while the
speciﬁcity decreases to 76% (95% CI 67e82; Table V). Sensitivity and
speciﬁcity are comparable to the overall values when using radi-
ography as the reference standard (Table VI). With arthroscopy as
the reference standard, both sensitivity and speciﬁcity increase to
69% (95% CI 62e75) and 93% (95% CI 86e96), respectively
(Table VII). When using only the clinical information as thereference standard, speciﬁcity is slightly decreased to 73% (95% CI
64e80), while sensitivity is markedly decreased to 39% (95% CI
26e54). Lastly, with open visual inspection of the tissues as refer-
ence standard the sensitivity increases to 86% (CI 65e96), while the
speciﬁcity drops to 56% (CI 15e91).
The agreement for assessing bias by the data extraction readers
was kappa¼ 0.70.
Discussion
This study examines the diagnostic performance of MRI in OA
compared with other clinical and research reference standards for
viewing synovial joint structural change. The comparative refer-
ence standards have themselves relative merits when used for
testing MRI techniques. Firstly, arthroscopy and histology, because
they view cartilage and other joint tissues directly, are most suit-
able for judging the performance of MRI in imaging cartilage
changes or meniscal degeneration. However, viewing cartilage
defects directly may or may not correlate with actual clinical OA
diagnosis. X-ray, on the other hand, cannot view cartilage directly,
Fig. 3. Plot showing speciﬁcity of MRI use in OA viewing various tissue types in the 16 studies with complete data.
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through assessment of joint space width. This provides a poor
reference standard with which to grade cartilage defects, as a lack
of change in joint space width does not preclude possible cartilageTable IV
Random-effects model for all tissue types and all reference standards in the 16
studies with complete data: DerSimonianeLaird
Estimate 95% CI I^2 P-value
Lower Upper
Speciﬁcity 0.824 0.768 0.868 0.850 <0.001
Sensitivity 0.610 0.531 0.683 0.938 <0.001
PVþ 0.846 0.799 0.884 0.833 <0.001
PV 0.570 0.427 0.702 0.977 <0.001
Accuracy 0.692 0.610 0.763 0.970 <0.001
DOR 7.874 4.688 13.226 0.891 <0.001
LRþ 3.218 2.328 4.450 0.901 <0.001
LR 0.484 0.400 0.586 0.914 <0.001defects on MRI.8 X-ray also visualizes osteophytes, changes in bone
contour and sclerosis. Because the KellgreneLawrence scale is
comprised of these four characteristics and has been used in OA
deﬁnition, correlation with radiographic ﬁndings could lend utility
to MRI in OA diagnosis.
The speciﬁcity is generally superior to sensitivity for nearly all
datasets in the studies included, suggesting that, based on the MRI
features used, MRI would be more useful in ruling out false positives
when a patient is already suspected of having OA by other measures.
However, because current diagnosis is performed with clinical and
radiologic means, until there is a separate, well-validated MRI-based
deﬁnition of OA, only those diagnostic measures based on reference
standards of arthroscopic or histologic deﬁnitions of OA can add to
a diagnosis made with the present diagnostic standards.
Not surprisingly, diagnostic performance, and more precisely
sensitivity is better with arthroscopy and histology as reference
standards compared with X-ray because they directly visualize
cartilage, as does MRI.
Fig. 4. Plot of summary ROC curve comparing MRI techniques with other reference
standards in the 16 studies with complete data: X-ray, clinical diagnosis, arthroscopy,
histology, direct visualization, and CT scan. Diagnostic accuracy is demonstrated by
plotting 1-speciﬁcity (x-axis) vs sensitivity (y-axis). The AUC is 0.804.
Fig. 6. Funnel plot of speciﬁcity in the 16 studies with complete data.
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as measured by even the more robust reference standards
(e.g., arthroscopy and histology), MRI is not currently useful as
a preliminary screen for identifying new cases of OA. Its lack of
utility in this case is especially clear given that for OA of the knee
the much cheaper, presently-used diagnostic tools of history, exam,
and radiography provide a better sensitivity: radiograph plus
physical exam at 91% and the CART from mid-eighty to mid-ninety
percent.4 In providing more clinical utility, likelihood ratios >10
and <0.1 are needed for strong evidence in respectively ruling in or
out a diagnosis, and most of those found in this study are far
from providing such support for a diagnosis either way.36 A well-
validated MRI-based deﬁnition of OA is needed before it can
supersede the current methods of diagnosis, and for this the correct
constellation of MRI features must be found to raise the sensitivity
and speciﬁcity of this imaging modality.
Radiography is currently used as a conﬁrmatory ﬁnding in the
clinical diagnosis of OA, as well as to rule out other possible diag-
noses when a thorough history and physical exam provesFig. 5. Funnel plot of sensitivity in the 16 studies with complete data.ambiguous. Even if MRI had the needed sensitivity to detect early
OA before it appears symptomatically in the clinic, or if it could
inform us on the stage of the disease from an anatomical or path-
ological standpoint, it would still provide no therapeutic advantage
as there are currently no available disease-modifying therapies for
OA. In addition MRI carries with it a large cost; an MRI of the knee
costs approximately 5e22 times that of a standard radiograph in
many health care settings.37,38 Given the prevalence of OA in the
general population, use of MRI in this setting would come at a great
expense. The only setting inwhich the use of MRI may be beneﬁcial
is in cases in which other diseases are high on the differential, and
they can be ruled out on MRI, or treated if present, e.g., early stage
avascular necrosis. Any argument for MRI use in OA diagnosis needs
to show a clear therapeutic beneﬁt to make up for the large
escalation in cost.
There were clearly some limitations to this study. The many
different MRI sequences used, the different tissues used, and the
various reference standards limit the usefulness and meaningful-
ness of any single value for sensitivity, speciﬁcity, PPV, NPV, LRþ,
and LR. Ideally the many studies would have used the same
parameters, tissue types and MRI sequences, to obtain a more
powerful and homogeneous diagnostic value. In addition, the
studies examined each had variations in the severity of OA
included, affecting their diagnostic measurements; it was beyond
the scope of this analysis to draw distinctions between degrees of
OA and the effect of these gradations on MRI performance. MoreTable V
Random-effects model of diagnostic data for all tissue types, using histology as the
reference standard (ﬁve datasets from four studies): DerSimonianeLaird
Estimate 95% CI I^2 P-value
Lower Upper
Speciﬁcity 0.755 0.675 0.820 0.520 0.244
Sensitivity 0.737 0.648 0.810 0.469 0.288
PVþ 0.704 0.484 0.858 0.883 0.001
PV 0.759 0.446 0.925 0.945 <0.001
Accuracy 0.745 0.679 0.802 0.628 0.146
DOR 10.030 5.361 18.765 0.474 0.283
LRþ 3.122 2.193 4.444 0.593 0.179
LR 0.353 0.265 0.471 0.342 0.386
Table VI
Random-effects model of diagnostic data for all tissue types, using X-ray as the
reference standard (six datasets from three studies): DerSimonianeLaird
Estimate 95% CI I^2 P-value
Lower Upper
Speciﬁcity 0.809 0.711 0.879 0.544 0.119
Sensitivity 0.607 0.497 0.708 0.708 0.017
PVþ 0.816 0.658 0.910 0.790 0.002
PV 0.615 0.474 0.739 0.817 0.001
Accuracy 0.698 0.633 0.757 0.598 0.076
DOR 8.389 4.517 15.583 0.425 0.224
LRþ 3.280 2.129 5.053 0.495 0.160
LR 0.475 0.376 0.602 0.572 0.096
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number of total defects noted rather than numbers of total joints or
numbers of patients.18e20,23,26,28,29,31,33,34 This skewed the weight
of each datapoint in the meta-analysis; ideally all of the studies
would have one datapoint per subject, or an equal number of
surfaces analysed per subject.
Due to the number of existing studies fulﬁlling the inclusion
criteria found in our search and their differing approaches, the
conclusions we can draw about detailed aspects of OA diagnosis
have limitations. In current clinical practice, diagnostic needs
which MRI could theoretically ﬁll are in differential diagnosis
(e.g., avascular necrosis), differentiation of OA into subcategories/
phenotypes, and in diagnosing a pre-OA state, i.e., identifying
structural change in patients with no symptoms or in those with
symptoms but lacking structural changes on radiograph. As this
review is focused on studies comparing the diagnostic performance
of MRI in detecting OA with other standards of reference, the
studies included do not address the question of an expanded
differential diagnosis nor creating subcategories of OA. Reich-
enbach et al. assess bone attrition on radiograph13 which could be
included in diagnosing pre-OA, and which has already been found
to be a potential target of therapy39. However, this was only one
study and not enough to draw larger conclusions from about
pre-OA diagnosis.
An important step in developing disease-modifying treatments
is to create clear and validated classiﬁcation criteria for the diag-
nosis of a pre-OA state. Pre-OA is deﬁned as the state before clinical
symptoms, or conventional radiologic markers of OA appear, but in
a patient who will progress to fully developed OA. Clearly such
a state cannot be deﬁned with current diagnostic deﬁnitions of OA,
but can only be detectedwith newermarkers, radiologic, histologic,
or otherwise. Possible evidence of this state has already been found
histologically.40 Detection of pre-OA could be demonstrated by
a prognostic study looking at various clinical and imaging features
at baseline and following them longitudinally to ascertain if disease
occurs. These markers, which may or may not seem usefulTable VII
Random-effects model of diagnostic data for all tissue types, using arthroscopy as
the reference standard (11 datasets from seven studies): DerSimonian-Laird
Estimate 95% CI I^2 P-value
Lower Upper
Speciﬁcity 0.926 0.857 0.963 0.928 <0.001
Sensitivity 0.687 0.617 0.749 0.826 <0.001
PVþ 0.869 0.766 0.931 0.915 <0.001
PV 0.826 0.699 0.907 0.975 <0.001
Accuracy 0.841 0.761 0.897 0.966 <0.001
DOR 32.110 12.682 81.300 0.926 <0.001
LRþ 9.280 4.776 18.033 0.923 <0.001
LR 0.357 0.290 0.440 0.825 <0.001currently, could then be measured for diagnostic usefulness against
a clinical endpoint years later, such as total knee arthroplasty. Those
markers which demonstrate better predictive validity could
potentiate a new, MRI-based deﬁnition of pre-OA in the future. The
capability to designate patients as pre-OA and likewise to follow
pre-OA disease activity, would allow testing of disease-modifying
therapies in this earlier, and hopefully more easily-altered, stage of
the disease.
This analysis found that MRI has some potential as a non-
invasive method of visualizing OA when compared with standard
radiograph, histology, gross dissection and other techniques. Based
on currently described MRI features of OA, MRI has more utility in
ruling out OAwhen otherwise suspected, than in detecting newOA.
However, with an overall sensitivity below that of clinical and
radiographic diagnosis and with these more cost-effective diag-
nostic tools currently used in the clinic there would seem to be no
indication for using MRI in routine clinical diagnosis at this time.
Given the current lack of disease-modifying therapeutic options
available for treating OA and the lack of validated classiﬁcation
criteria for diagnosing early OA, MRI should not be used in a clinical
setting for diagnosis of OA.Contributions
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